Necrosis and Glioblastoma: A Friend or a Foe? A Review and a Hypothesis
暂无分享,去创建一个
Raymond Sawaya | G. Fuller | B. Aggarwal | F. Lang | R. Sawaya | S. Raza | D. Wildrick | Gregory N Fuller | Bharat B Aggarwal | Frederick F Lang | Shaan M Raza | David M Wildrick
[1] P. Nicotera,et al. Intracellular Adenosine Triphosphate (ATP) Concentration: A Switch in the Decision Between Apoptosis and Necrosis , 1997, The Journal of experimental medicine.
[2] A. Koong,et al. Candidate genes for the hypoxic tumor phenotype. , 2000, Cancer research.
[3] S. Targan,et al. TNF-α antagonists for the treatment of Crohn’s disease , 2000 .
[4] K. Hajjar,et al. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor , 1986, The Journal of experimental medicine.
[5] M. Weber,et al. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. , 1993, Science.
[6] W. Fiers,et al. More than one way to die: apoptosis, necrosis and reactive oxygen damage , 1999, Oncogene.
[7] I. Verma,et al. Induction of proto-oncogene JUN/AP-1 by serum and TPA , 1988, Nature.
[8] A. Wyllie. The biology of cell death in tumours. , 1985, Anticancer research.
[9] P. Campbell,et al. Immune protection and control of inflammatory tissue necrosis by gamma delta T cells. , 1994, Journal of immunology.
[10] P. Nicotera,et al. Energy supply and the shape of death in neurons and lymphoid cells , 1997, Cell Death and Differentiation.
[11] J. Tschopp,et al. Apoptosis induced by death receptors. , 2000, Pharmaceutica acta Helvetiae.
[12] G. Semenza,et al. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. , 2001, Cancer research.
[13] W. Fiers,et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Vilček,et al. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Menger,et al. Characterization of Angiogenesis and Microcirculation of High–Grade Glioma: An Intravital Multifluorescence Microscopic Approach in the Athymic Nude Mouse , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[16] K. Hossmann,et al. Blood Flow and Regulation of Blood Flow in Experimental Peritumoral Edema , 1981, Stroke.
[17] N. Weidner,et al. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. , 1994, The American journal of pathology.
[18] R. Sawaya,et al. Biological significance of tissue plasminogen activator content in brain tumors. , 1991, Journal of neurosurgery.
[19] J. Miyazaki,et al. Tumor necrosis factor alpha signaling pathway and apoptosis in pancreatic β cells , 1999 .
[20] T. Gelehrter,et al. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. , 1986, The Journal of clinical investigation.
[21] Z. Gokaslan,et al. Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors , 1997, Clinical & Experimental Metastasis.
[22] R. Medcalf,et al. Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes , 1988, The Journal of experimental medicine.
[23] G. Martin,et al. Ras-independent oncogenic transformation by an EGF-receptor mutant. , 2000, Journal of cell science.
[24] C. Vinson,et al. Fibrin fragment induction of plasminogen activator inhibitor transcription is mediated by activator protein-1 through a highly conserved element. , 1999, Blood.
[25] J. Folkman,et al. Tumor angiogenesis: a quantitative method for histologic grading. , 1972, Journal of the National Cancer Institute.
[26] P. Vaupel,et al. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.
[27] L. Rubin,et al. Activated Phosphatidylinositol 3-Kinase and Akt Kinase Promote Survival of Superior Cervical Neurons , 1997, The Journal of cell biology.
[28] R. Sawaya,et al. Plasminogen activator activity and molecular weight patterns in human brain tumors. , 1988, Journal of neurosurgery.
[29] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[30] R. Sawaya,et al. Postoperative venous thromboembolism and brain tumors: part III. Biochemical profile , 2004, Journal of Neuro-Oncology.
[31] L. Gooding,et al. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. , 1988, Journal of immunology.
[32] A. Brunet,et al. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts , 1993, The Journal of cell biology.
[33] W. Fiers,et al. Molecular mechanisms of tumor necrosis factor‐induced cytotoxicity , 1994, FEBS letters.
[34] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[35] A. Harris,et al. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. , 2001, Cancer research.
[36] G. Jayson,et al. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells. , 1997, British Journal of Cancer.
[37] Raymond Sawaya,et al. Prognostic significance of preoperative MRI scans in glioblastoma multiforme , 2004, Journal of Neuro-Oncology.
[38] R. Rosenberg,et al. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells , 1988, Molecular and cellular biology.
[39] B. Aggarwal,et al. TNF-Induced Signaling in Apoptosis , 1999, Journal of Clinical Immunology.
[40] J. S. Rao,et al. Plasminogen activator inhibitor-1 in brain tumors: relation to malignancy and necrosis. , 1995, Neurosurgery.
[41] L. Chess,et al. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.
[42] Vijay R Baichwal,et al. Apoptosis: Activate NF-κB or die? , 1997, Current Biology.
[43] N. K. Sah,et al. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. , 2000, Cancer research.
[44] K. Kinzler,et al. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. Wyllie,et al. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. , 1994, The American journal of pathology.
[46] D. Hallahan,et al. Tumor necrosis factor α (TNF-α) gene therapy targeted by ionizing radiation selectively damages tumor vasculature , 1996 .
[47] A. Ullrich,et al. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. , 1993, Cancer research.
[48] R. Cotran,et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.
[49] Eric C. Holland,et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice , 2000, Nature Genetics.
[50] S. Ghosh,et al. Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.
[51] P. Tsichlis,et al. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[52] Nelson Lau,et al. Signal transduction pathways and their relevance in human astrocytomas , 1997, Journal of Neuro-Oncology.
[53] N. Sato,et al. Effects of tumor necrosis factor (TNF) on transplanted tumors induced by methylcholanthrene in mice , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.
[54] L. Platanias,et al. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors. , 2000, Biochemical and biophysical research communications.
[55] H. Allgayer,et al. A region between -141 and -61 bp containing a proximal AP-1 is essential for constitutive expression of urokinase-type plasminogen activator receptor. , 1999, European journal of biochemistry.
[56] C. Der,et al. Oncogenic Ha-Ras-induced Signaling Activates NF-κB Transcriptional Activity, Which Is Required for Cellular Transformation* , 1997, The Journal of Biological Chemistry.
[57] J F Kerr,et al. Shrinkage necrosis: A distinct mode of cellular death , 1971, The Journal of pathology.
[58] R K Jain,et al. Determinants of tumor blood flow: a review. , 1988, Cancer research.
[59] K. Hamilton,et al. Tumour necrosis factor-α blockade: a new era for effective management of rheumatoid arthritis , 2000, Expert opinion on pharmacotherapy.
[60] A. Wyllie. Cell death: a new classification separating apoptosis from necrosis , 1981 .
[61] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[62] P. Black,et al. Expression of platelet derived growth factor and platelet derived growth factor receptor mRNA in a glioblastoma from a patient with Li-Fraumeni syndrome. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[63] D. Vaux. Toward an understanding of the molecular mechanisms of physiological cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[64] A. Krüger,et al. Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis. , 2001, Cancer research.
[65] C. Marshall,et al. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.
[66] T. Oostendorp,et al. Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. , 1995, British Journal of Cancer.
[67] D. Groothuis,et al. Regional blood flow in ethylnitrosourea‐induced brain tumors , 1983, Annals of neurology.
[68] M. Menger,et al. Vascular Microenvironment in Gliomas , 2000, Journal of Neuro-Oncology.
[69] A. Giaccia,et al. Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. , 2001, Cancer research.
[70] E Farber,et al. Programmed cell death: necrosis versus apoptosis. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[71] D. Stern,et al. Modulation of endothelial cell hemostatic properties by tumor necrosis factor , 1986, The Journal of experimental medicine.
[72] Georg Breier,et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.
[73] D. Bigner,et al. Regional measurements of blood flow in experimental RG-2 rat gliomas. , 1983, Cancer research.
[74] A. Aguzzi,et al. Angiogenesis in Transgenic Models of Multistep Carcinogenesis , 2004, Journal of Neuro-Oncology.
[75] B. Aggarwal,et al. Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells. , 1996, Cancer research.
[76] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.